Concussion / mTBI

Advanced Neurotechnology | Accelerated Recovery

Post-Concussion Syndrome (PCS) can be difficult to treat efficiently with conventional rehabilitation. Traditional therapies often leave persistent vestibular, visual, sensorimotor, and cognitive deficits unresolved, leading to prolonged recovery, reduced functional capacity, and diminished quality of life.

Even after symptoms appear to resolve, hidden neurological deficits can remain, affecting cognition, neuromuscular control, and performance. Research shows that athletes returning to play after a concussion face more than three times the risk of secondary lower-extremity injuries—including ACL tears and ankle sprains—within the first 90 days, likely due to unresolved neuromotor impairments.

Conventional Rehab Often Falls Short

Neurotechnology Designed to Accelerate Recovery

GyroStim is engineered with technological advantages designed to overcome these limitations. Clinical evidence shows that technology-assisted multimodal neurorehabilitation with GyroStim, when combined with conventional therapy, can accelerate recovery rates by up to 8×—helping restore neurological function and resolve persistent deficits more efficiently.

Key Statistical Findings

Comparing GyroStim treatment to SOC, there was a significant difference in treatment duration (GyroStim: 1.3 ± 0.5 weeks vs. SOC: 13.0 ± 4.2 weeks; p < 0.001) and number of PT sessions (GyroStim: 9.2 ± 6.3 vs. SOC: 13.5 ± 2.4; p < 0.001).
Comparing GyroStim treatment to SOC, there is a non-significant trend for differences in Therapeutic Dose-Response (GyroStim: 12.9 ± 13.4 DHI units vs. SOC: 1.6 ± 0.6 DHI units; p = 0.13).

GyroStim Real-World Clinical Insights

Retrospective real-world data from multi-site clinical chart reviews comparing standard-of-care (SOC) physical therapy with GyroStim combined with SOC revealed substantial differences in concussion recovery efficiency. Patients receiving GyroStim treatment once to twice daily, in addition to SOC, achieved recovery rates averaging up to 8× faster, highlighting treatment efficiency as a key differentiator.

Analysis of this data also demonstrated a statistically significant dose–response relationship, with higher treatment frequency associated with accelerated rehabilitation. These findings provide compelling real-world evidence that GyroStim can dramatically compress recovery timelines compared with conventional therapy alone. While retrospective in design, these insights reflect current clinical practice, support new hypotheses for prospective studies, and represent a potential paradigm shift in post-concussion rehabilitation.

Key Clinical Findings

• Higher treatment frequency with GyroStim was significantly associated with faster rehabilitation.
• GyroStim treatment markedly accelerated recovery compared with SOC alone.
• GyroStim demonstrated substantially greater rehabilitation efficiency than conventional therapy.

Recovery You Can trust

GyroStim is FDA-cleared, Breakthrough Device–designated, and in clinical use since 2010. Its precise, data-driven approach delivers safe, efficient, high-impact neurorehabilitation for faster, more reliable recovery.

Concussion Case Details:

01/20/26: Sports-Related Concussion, no LOC.

Severity Score SCOAT6 = 62

01/23/26: Began GyroStim therapy

Completed 9 sessions across 5 days in a row.

01/27/26: Completed GyroStim therapy

Severity Score SCOAT6 = 2

Concussions can affect athletes in any sport. Tyler Evans, the 2025 U.S. National Champion in Modern Pentathlon, was struck in the face by a bell guard during fencing practice, resulting in a concussion. After two days of rest, he began twice-daily GyroStim sessions and shares his experience of accelerated recovery.

The Fast Track Back from Concussion

Click below for video of concussion treatment.

First 24–48 Hours
Current concussion care guidelines* recommend a brief period of physical and cognitive rest immediately after injury.

Early Active Rehabilitation

Research now shows that gradual and targeted vestibular, visual, and sensorimotor stimulation can help the brain recover more efficiently.

Accelerated Neurorehabilitation with GyroStim

GyroStim delivers precisely dosed, robotic-assisted multimodal neurorehabilitation designed to efficiently stimulate the systems typically affected by concussion—helping many patients progress through recovery dramatically faster than with conventional therapy alone.

Concussions can derail training, performance, careers, and daily life. GyroStim accelerates recovery so athletes can return to peak performance safely and confidently.

Get Back in the Game—Faster and Safer

Up to 8× Faster Recovery: Clinical chart reviews show GyroStim plus conventional therapy restores function dramatically faster than standard care alone.
Protect Performance: GyroStim uniquely targets vestibular, visual, sensorimotor, and cognitive systems to rehabilitate coordination, reaction time, and focus.
Reduce Re-Injury Risk: Athletes returning after concussion face 3× higher risk of lower-body injuries—GyroStim supports safer reintegration.
FDA-Cleared & Breakthrough Designated: The only device designed for precise, multisensory neurorehabilitation.

Intensity and Density Matter

The TDR per Week vs. GyroStim Treatment Density chart illustrates a nonlinear relationship between treatment density (frequency) and therapeutic dose-response. This indicates that higher treatment density with GyroStim was associated with accelerated therapeutic efficiency and significantly faster rate of rehabilitation.

A growing body of evidence indicates that earlier, more frequent (treatment density) and more intensive (treatment intensity) neurorehabilitation following concussion or mild traumatic brain injury (mTBI) is associated with improved functional outcomes and greater symptom reduction. Multiple studies demonstrate that active, multimodal, and targeted rehabilitation interventions lead to faster recovery compared with prolonged rest alone, particularly in patients with persistent post-concussion symptoms.

Consistent with this evidence, the National Institutes of Health (NIH) has noted a shift away from extended rest toward early, active, and targeted neurorehabilitation as a more effective strategy for promoting recovery following concussion.

Clinical chart review data courtesy of Dr. Kim Fox, DPT, Clinical Director, AVORA Health, Asheville, North Carolina.

Collectively, these findings suggest a meaningful evolution in post-concussion management. Instead of incremental improvement over months, high-density, multimodal neurorehabilitation with GyroStim is associated with recovery timelines measured in weeks—or even days—dramatically faster than conventional therapy alone. Supported by FDA clearance, Breakthrough Device designation, and a growing body of research, GyroStim represents a paradigm shift in neurorehabilitation, accelerating functional recovery, reducing long-term disability and healthcare burden, and improving quality of life for millions each year.